BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10569746)

  • 1. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.
    Young RS; Fortney K; Haley JC; Hood AF; Campagnari AA; Wang J; Bozue JA; Munson RS; Spinola SM
    Infect Immun; 1999 Dec; 67(12):6335-40. PubMed ID: 10569746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans.
    Young RS; Filiatrault MJ; Fortney KR; Hood AF; Katz BP; Munson RS; Campagnari AA; Spinola SM
    Infect Immun; 2001 Jun; 69(6):4180-4. PubMed ID: 11349097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DltA mutant of Haemophilus ducreyi Is partially attenuated in its ability to cause pustules in human volunteers.
    Janowicz D; Leduc I; Fortney KR; Katz BP; Elkins C; Spinola SM
    Infect Immun; 2006 Feb; 74(2):1394-7. PubMed ID: 16428791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection.
    Fortney KR; Young RS; Bauer ME; Katz BP; Hood AF; Munson RS; Spinola SM
    Infect Immun; 2000 Nov; 68(11):6441-8. PubMed ID: 11035757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis.
    Gibson BW; Campagnari AA; Melaugh W; Phillips NJ; Apicella MA; Grass S; Wang J; Palmer KL; Munson RS
    J Bacteriol; 1997 Aug; 179(16):5062-71. PubMed ID: 9260947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an isogenic major outer membrane protein-deficient mutant in the human model of Haemophilus ducreyi infection.
    Throm RE; Al-Tawfiq JA; Fortney KR; Katz BP; Hood AF; Slaughter CA; Hansen EJ; Spinola SM
    Infect Immun; 2000 May; 68(5):2602-7. PubMed ID: 10768950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.
    Janowicz DM; Fortney KR; Katz BP; Latimer JL; Deng K; Hansen EJ; Spinola SM
    Infect Immun; 2004 Aug; 72(8):4528-33. PubMed ID: 15271912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi.
    Sun S; Schilling B; Tarantino L; Tullius MV; Gibson BW; Munson RS
    J Bacteriol; 2000 Apr; 182(8):2292-8. PubMed ID: 10735874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection.
    Palmer KL; Thornton AC; Fortney KR; Hood AF; Munson RS; Spinola SM
    J Infect Dis; 1998 Jul; 178(1):191-9. PubMed ID: 9652440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilus-deficient mutant of Haemophilus ducreyi is virulent in the human model of experimental infection.
    Al-Tawfiq JA; Bauer ME; Fortney KR; Katz BP; Hood AF; Ketterer M; Apicella MA; Spinola SM
    J Infect Dis; 2000 Mar; 181(3):1176-9. PubMed ID: 10720550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the Haemophilus ducreyi luxS gene affects the virulence of this pathogen in human subjects.
    Labandeira-Rey M; Janowicz DM; Blick RJ; Fortney KR; Zwickl B; Katz BP; Spinola SM; Hansen EJ
    J Infect Dis; 2009 Aug; 200(3):409-16. PubMed ID: 19552526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.
    Spinola SM; Li W; Fortney KR; Janowicz DM; Zwickl B; Katz BP; Munson RS
    Infect Immun; 2012 Feb; 80(2):679-87. PubMed ID: 22144477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.
    Mount KL; Townsend CA; Rinker SD; Gu X; Fortney KR; Zwickl BW; Janowicz DM; Spinola SM; Katz BP; Bauer ME
    Infect Immun; 2010 Mar; 78(3):1176-84. PubMed ID: 20086092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers.
    Janowicz D; Luke NR; Fortney KR; Katz BP; Campagnari AA; Spinola SM
    Microb Pathog; 2006 Mar; 40(3):110-5. PubMed ID: 16426809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Flp proteins by Haemophilus ducreyi is necessary for virulence in human volunteers.
    Janowicz DM; Cooney SA; Walsh J; Baker B; Katz BP; Fortney KR; Zwickl BW; Ellinger S; Munson RS
    BMC Microbiol; 2011 Sep; 11():208. PubMed ID: 21939541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genes involved in the expression of atypical lipooligosaccharide structures from a second class of Haemophilus ducreyi.
    Post DM; Munson RS; Baker B; Zhong H; Bozue JA; Gibson BW
    Infect Immun; 2007 Jan; 75(1):113-21. PubMed ID: 17030566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers.
    Young RS; Fortney KR; Gelfanova V; Phillips CL; Katz BP; Hood AF; Latimer JL; Munson RS; Hansen EJ; Spinola SM
    Infect Immun; 2001 Mar; 69(3):1938-42. PubMed ID: 11179379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus ducreyi requires an intact flp gene cluster for virulence in humans.
    Spinola SM; Fortney KR; Katz BP; Latimer JL; Mock JR; Vakevainen M; Hansen EJ
    Infect Immun; 2003 Dec; 71(12):7178-82. PubMed ID: 14638812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative experience with Haemophilus ducreyi 35000 in the human model of experimental infection.
    Al-Tawfiq JA; Harezlak J; Katz BP; Spinola SM
    Sex Transm Dis; 2000 Feb; 27(2):111-4. PubMed ID: 10676978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans.
    Bauer ME; Townsend CA; Doster RS; Fortney KR; Zwickl BW; Katz BP; Spinola SM; Janowicz DM
    J Infect Dis; 2009 Mar; 199(5):684-92. PubMed ID: 19199547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.